Background, Motivation and Objective
Tumor hypoxia has been shown to decrease the sensitivity of solid tumors to radiation. Systemic efforts to increase tumor oxygenation levels immediately prior to therapy, however, have largely proven unsuccessful. The objective of this work was to determine the utility of oxygen-filled, ultrasound sensitive microbubbles for locally delivering oxygen and sensitizing tissue to radiation in a breast cancer model.
Statement of Contribution/Methods
Surfactant-shelled oxygen microbubbles (SE61O2) or nitrogen microbubbles (SE61N2) were prepared using previously described techniques. Human breast cancer cells (MDA-MB-231) were subcutaneously implanted into the hind limb of 28 female athymic mice and grown to maximum diameters of 5-7 mm. Animals received 0.1 ml injections of each SE61 agent or saline with and without ultrasound (S3000 Helx with a 9L4 probe generating 1.5 second flash pulses (MI=1.35) with 3 second microbubble replenishment periods; Siemens Healthineers, Mountain View, CA). In the first 8 animals, the ability of microbubbles to elevate tumoral partial oxygen pressure (pO2) was monitored using an OxyLite 2000 with a bare fiber probe (Oxford Optronix, Oxford, UK). The remaining 20 animals were assigned to treatment groups receiving A) SE61O2 + ultrasound + radiation (5 Gy), B) SE61O2 + ultrasound (no radiation), C) ultrasound + radiation (no SE61O2), D) SE61N2 + ultrasound + radiation, or E) SE61O2 + radiation (no ultrasound). Tumor growth was monitored over 5 weeks and compared to determine if SE61O2 sensitized tumors to radiation.
Results/Discussion
In the oxygenation monitoring experiments, tumors treated with SE61O2 and ultrasound showed a pO2 increase in all animals with a peak increase of 22.9±6.4 mmHg. No changes in pO2 levels were detected after injection of SE61O2 without ultrasound or saline or SE61N2 with ultrasound (largest change < 0.5 mmHg). Peak oxygenation was achieved 75±28.9 seconds post injection. For therapy experiments, normalized tumor volume 1 month post treatment was found to be A) 1.5±1.2 fold for SE61O2 + ultrasound + radiation, B) 41.7±62.7 fold for SE61O2 + ultrasound, C) 4.3±1.2 fold for ultrasound + radiation, D) 9.3±4.7 fold for SE61N2 + ultrasound + radiation, and E) 14.7±14.4 fold for SE61O2 + radiation. These preliminary results indicate that the combination of SE61O2 with ultrasound elevates breast tumor oxygenation levels, and that this elevation leads to improved tumoral radio-sensitivity and treatment response.
